|
Development of a fully human T cell engaging bispecific antibody for the treatment of multiple myeloma. |
| |
|
Employment - Tenera Healthcare |
Leadership - Tenera Healthcare |
Stock and Other Ownership Interests - Tenera Healthcare |
| |
|
|
Stock and Other Ownership Interests - TeneoBio |
| |
|
|
Stock and Other Ownership Interests - TeneoBio |
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
Patents, Royalties, Other Intellectual Property - Teneobio Inc. |
| |
|
|
Stock and Other Ownership Interests - TeneoBio |
| |
|
|
Stock and Other Ownership Interests - TeneoBio |
| |
|
|
Stock and Other Ownership Interests - TeneoBio |
| |
|
No Relationships to Disclose |
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
Patents, Royalties, Other Intellectual Property - Teneobio Inc. |
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
| |
|
Research Funding - TeneoBio (Inst) |
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
Patents, Royalties, Other Intellectual Property - Teneobio Inc. |
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |